Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/43038
DC FieldValueLanguage
dc.contributor.authorOrdoñez, R.
dc.contributor.authorHenríquez-Hernández, L. A.
dc.contributor.authorFederico, M.
dc.contributor.authorValenciano, A.
dc.contributor.authorPinar, B.
dc.contributor.authorLloret, M.
dc.contributor.authorBordón, E.
dc.contributor.authorRodríguez-Gallego, C.
dc.contributor.authorLara, P. C.
dc.date.accessioned2018-11-21T12:12:37Z-
dc.date.available2018-11-21T12:12:37Z-
dc.date.issued2014
dc.identifier.issn0179-7158
dc.identifier.urihttp://hdl.handle.net/10553/43038-
dc.description.abstractBackground and purpose. A close relationship exists between immune response and tumor behavior. This study aimed to explore the associations between radiation-induced apoptosis (RIA) in peripheral blood lymphocytes (PBL) and clinical pathological variables. Furthermore, it assessed the role of RIA as a prognostic factor for survival in cervical carcinoma patients.Patients and methods. Between February 1998 and October 2003, 58 consecutive patients with nonmetastatic, localized stage I-II cervical carcinoma who had been treated with radiotherapy (RT) +/- A chemotherapy were included in this study. Follow-up ended in January 2013. PBL subpopulations were isolated and irradiated with 0, 1, 2 and 8 Gy then incubated for 24, 48 and 72 h. Apoptosis was measured by flow cytometry and the beta value, a parameter defining RIA of lymphocytes, was calculated.Results. Mean follow-up duration was 111.92 +/- 40.31 months. Patients with lower CD8 T lymphocyte beta values were at a higher risk of local relapse: Exp(B) = 5.137, confidence interval (CI) 95 % = 1.044-25.268, p = 0.044. Similar results were observed for regional relapse: Exp(B) = 8.008, CI 95 % = 1.702-37.679, p = 0.008 and disease relapse: Exp(B) = 6.766, CI 95 % = 1.889-24.238, p = 0.003. In multivariate analysis, only the CD8 T lymphocyte beta values were found to be of prognostic significance for local disease-free survival (LDFS, p = 0.049), regional disease-free survival (RDFS, p = 0.002), metastasis-free survival (MFS, p = 0.042), disease-free survival (DFS, p = 0.001) and cause-specific survival (CSS p = 0.028).Conclusion. For the first time, RIA in CD8 T lymphocytes was demonstrated to be a predictive factor for survival in cervical carcinoma patients.
dc.publisher0179-7158
dc.relation.ispartofStrahlentherapie und Onkologie
dc.sourceStrahlentherapie und Onkologie[ISSN 0179-7158],v. 190, p. 210-216
dc.subject.otherGrowth-Factor-Beta
dc.subject.otherClinical Toxicity
dc.subject.otherCancer Patients
dc.subject.otherTgf-Beta
dc.subject.otherRadiation
dc.subject.otherCells
dc.subject.otherHypoxia
dc.subject.otherTumor
dc.subject.otherExpression
dc.subject.otherPrediction
dc.titleRadio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients
dc.typeinfo:eu-repo/semantics/Articlees
dc.typeArticlees
dc.identifier.doi10.1007/s00066-013-0488-x
dc.identifier.scopus84893797725-
dc.identifier.isi000330623000011
dc.contributor.authorscopusid37261658100
dc.contributor.authorscopusid15829708200
dc.contributor.authorscopusid57201785606
dc.contributor.authorscopusid55382811900
dc.contributor.authorscopusid54904204300
dc.contributor.authorscopusid6507421079
dc.contributor.authorscopusid7003855087
dc.contributor.authorscopusid24402677200
dc.contributor.authorscopusid6602114379
dc.contributor.authorscopusid7004374085
dc.description.lastpage216
dc.description.firstpage210
dc.relation.volume190
dc.type2Artículoes
dc.contributor.daisngid2115479
dc.contributor.daisngid465624
dc.contributor.daisngid29956480
dc.contributor.daisngid13991533
dc.contributor.daisngid1285881
dc.contributor.daisngid802813
dc.contributor.daisngid34952053
dc.contributor.daisngid2045042
dc.contributor.daisngid591076
dc.contributor.wosstandardWOS:Ordonez, R
dc.contributor.wosstandardWOS:Henriquez-Hernandez, LA
dc.contributor.wosstandardWOS:Federico, M
dc.contributor.wosstandardWOS:Valenciano, A
dc.contributor.wosstandardWOS:Pinar, B
dc.contributor.wosstandardWOS:Lloret, M
dc.contributor.wosstandardWOS:Bordon, E
dc.contributor.wosstandardWOS:Rodriguez-Gallego, C
dc.contributor.wosstandardWOS:Lara, PC
dc.date.coverdateFebrero 2014
dc.identifier.ulpgces
dc.description.sjr1,099
dc.description.jcr2,914
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Medio Ambiente y Salud-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0003-3237-0316-
crisitem.author.orcid0000-0002-4344-8644-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameHenríquez Hernández, Luis Alberto-
crisitem.author.fullNameBordón Rodríguez, Elisa de los Reyes-
crisitem.author.fullNameRodríguez Gallego, José Carlos-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

20
checked on Mar 30, 2025

WEB OF SCIENCETM
Citations

17
checked on Mar 30, 2025

Page view(s)

27
checked on Jul 8, 2023

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.